Inhibition of human basophil activation by high dilutions of histamine
[1] Sainte-Laudy J, Belon P. Inhibition of human basophil activation by high dilutions of histamine. Agents Actions 1993; 38 (Special conference issue): C245-C247.
Inhibition of human basophil degranulation by successive histamine dilutions : Results of a European multi-center trial
[2] Belon P, Cumps J, Ennis M et al. Inhibition of human basophil degranulation by successive histamine dilutions : Results of a European multi-center trial. Inflam Res 1999; 48 (Suppl, 1): S17-S18.
Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry
[3] Sainte-Laudy J, Belon P. Analysis of immunosuppressive activity of serial dilutions of histamine on human basophil activation by flow cytometry. Inflam Res 1996; 45 (Suppl. 1): S33-S34.
Analysis of anti-IgE and allergen induced basophil activation by flow cytometry. Comparison with histamine release
[4] Sainte-Laudy J, Sabbah A, Vallon C et al. Analysis of anti-IgE and allergen induced basophil activation by flow cytometry. Comparison with histamine release. Inflam Res 1998; 47: 401-8.
Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil activation: Effect of cimetidine
[5] Sainte-Laudy J, Belon P. Application of flow cytometry to the analysis of the immunosuppressive effect of histamine dilutions on human basophil activation: Effect of cimetidine. Inflamm Res 1997; 46 (Suppl. 1): S27-S28.
Hormesis: A highly generalizable and reproductible phenomenon with important implications for risk assessment
[7] Calabrese EJ, Baldwin LA, Holland CD. Hormesis: a highly generalizable and reproductible phenomenon with important implications for risk assessment. Risk Anal 1999; 19: 261-81.